2月4日,和铂医药-B(02142)盘中上涨5.08%,截至10:39,报3.93元/股,成交968.42万元。
和铂医药控股有限公司是一家全球化生物制药企业,专注于肿瘤及免疫性疾病领域的创新药研发及商业化。公司的业务包括自主研发、联合开发创新药物,对外技术授权,以及与全球顶尖学术机构及生物医药公司的创新合作。
截至2024年中报,和铂医药-B营业总收入1.69亿元、净利润1014.86万元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.